management, measurement and reporting on intangible

1
Current developments and outlook on European
science discussionDr. Christian PatermannDG
Research
2nd EPSO Conference Interactions in Plant
Biology cells, plants and communities Hotel
Continental Terme, Ischia, Italy 10 14 October
2004
2
Current research policy and the 6th Framework
programme
3
EU Research Policy - Objectives

• Towards a European research area COM 2000(6)
  Jan 2000
• Proposes better framework conditions to foster
  integration of research activities and
  coordination of research and innovation policies
  to build the European Research Area an internal
  market for research, researchers and knowledge
• Lisbon Summit - March 2000
• Sets a strategic goal for Europe to become the
  most competitive and dynamic knowledge-based
  economy in the world by 2010
• Investing in research an action plan for
  Europe COM 2003(226) June 2003
• Proposes measures and actions to increase
  investment in European RD to 3 of GDP of
  which 2/3 from private sector - by 2010

4
EU biotechnology policy

• Stockholm Summit - March 2001
• Identifies biotechnology as a frontier technology
  and requests the Commission, together with the
  Council, to examine measures required to utilise
  the full potential of biotechnology and
  strengthen the European biotechnology sector's
  competitiveness
• Commission Communication (COM/2002/27)- Jan 2002
• Life Sciences and Biotechnology a Strategy for
  Europe
• Policy orientations and a 30-point Action Plan
• EC Communication (COM/2003/96) - March 2003
• 1st progress report on EU biotech strategy
• Highlights the necessity of a clear and
  consistent policy within the Member States on
  biotechnology to achieve the goals set at the
  Lisbon, Stockholm and Barcelona Councils
• EC Communication (COM/2004/50) - April 2004
• 2nd progress report on EU biotech strategy
• Highlights progress (GMO legislation) and
  failures (IPR legislation) competitiveness in
  biotech advisory group of business leaders and
  researchers established need to address newly
  emerging areas of biotechnolgy (genetic testing,
  animal biotech, industrial biotech, etc.)

5
A European Strategy for Life Sciences and
Biotechnology The Action Plan - COM (2002) 27
6
Sixth Framework
Programme
2002
-
2006
(Global budget European Community 16.270 M )
7
Biotech financing through EU FWPs

• FWP 6 financing available for biotech increased
  by 20 as compared to FWP5
• In the first year of FWP 6 more than 810m were
  allocated to research in the biotech sector
• More than 2700 laboratories and companies were
  involved, including 400 SMEs
• Human resources and mobility play a key element
  in the acquisition and transfer of knowledge
  the Commission has increased the budget for this
  area to 1.5b (almost double from FWP5)

8
Priority 1 Life Sciences, Genomics and
Biotechnology for Health (FP6)

• Advanced Genomics and its applications for
  health (1100 M)
• Fundamental knowledge and basic tools for
  functional genomics
• in all organisms
• (Structural genomics proteomics comparative
  genomics bioinformatics
• Multidisciplinary genomics approaches to
  basic biological processes)
• Application of knowledge and technologies in the
  field of
• genomics and biotechnology for health
• (Technology platforms support to start-up
  companies)

• Combating major diseases (1155 M)
• Application-oriented approach to medical
  genomics knowledge
• (Cardiovascular disease, diabetes and rare
  diseases resistance to
• antibiotics Studying the brain and combating
  diseases of the nervous
• system Studying human development and the
  ageing process)
• Broader biomedical approach
• (cancer, poverty-related infectious diseases)

9
Priority 5 Food Quality and Safety

• Epidemiology of food related diseases and
  allergies
• Impact of food on health
• Traceability processes
• Methods of analysis/detection and control of
  chemical
• contaminants and pathogenic microorganisms
• Safer production methods and healthier
  foodstuffs
• Impact of Animal feed on Human Health
• Environmental health risks

10
Priority 5 Food quality and safety Grain Legumes
Integrated Project
11
Priority 1 Life Sciences, biotechnology and
genomics for healthPharma-Planta Integrated
Project

• Production of useful pharmaceuticals in
  genetically modifed crops
• to produce vaccines and other treatments for
  HIV/Aids, rabies and TB
• to decrease costs of production and thereby
  encouraging use in developing countries
• First products to be developed
• antibody to block HIV transmission
• Post-bite vaccine for rabies, a significant
  killer in Africa and southeast asia
• Project involves 39 labs in 11 European countries
  and cooperation with South African researchers
• Led by Fraunhofer Institute for molecular biology
  and ecology in Aachen (DE)
• Scientific co-ordination by St. Georges Hospital
  Medical School in London (UK)
• EU contribution of 12 million

12
ERA-NET co-ordination action in plant genomics
(ERA-PG)

• Participants ERA-PG builds on national research
  programmes in plant genomics (NL, AT, BE, DK, FI,
  FR, DE, IT, NO, SP, UK). Other states may join
  (BG, EE, GR, HU, IE, PO, PT, RO, SE)
• Objectives
• improved co-ordination of national plant
  genomics research programmes
• optimising the huge investments required for
  plant genomics research and supporting policies
  with respect to competitiveness
• creating long term perspectives and improved
  validation of RTD strategies
• providing a co-ordinated response towards common
  challenges such as contributing to safeguard the
  production of safe and healthy food for the
  increasing world population.
• Means information exchange, web portal,
  short-term exchange of program managers,
  benchmarking, joint database of experts, position
  papers

13
Outlook

• FP7
• Technology Platforms
• The knowledge-based bio-economy

14
Developments towards FP7 (2006-2010)

• Financial Perspectives 2007 2013 (Feb).
  Proposed doubling of EU research budget
• Role of EU research support complement,
  reinforce, and strengthen the impact of national
  actions (collaboration the diffusion of
  knowledge the creation of critical masses of
  financial and human resources etc.)
• FP6 introduced range of initiatives to enhance
  this value added and provide more structured
  support. Now necessary to go a step further

15
Science and Technology, the key to Europes
future - guidelines for future European Union
policy to support research

• Commissions Communication on Future Research
  Policy (16 June 2004) to launch political debate
  ahead of Proposals for FP7 (early 2005)
• 6 major objectives to increase the impact of EUs
  actions and 2 new fields of research space and
  security

• Document and online consultation
• http//europa.eu.int/comm/research/future/index_en
  .html

16
Science Technology, the key to Europes future
- Key axes
6 axes
17

• Europe and Basic Research
• January 2004, COM(2004)9
• Basic research has an important impact on
  economic performance
• Europe is not making the most of its research
  capabilities
• A new funding mechanism is needed at European
  level to reinforce excellence
• based on competitive support to individual teams
• sole criterion for selection should be scientific
  excellence
• (a different form of added value from European
  action)

18

• Next steps the road map
• Broad consultation
• Development of the structure
• Mandate, structure and membership of European
  Research Council
• Development of operational base (organisation,
  grant, evaluation, etc.)
• Added value (how to maximise impact)
• Coordination with other FP axes

19
Timetable 2004 Communication on the future of
research 2004 Choice of structure and
operational methodology Early 2005 FP7
proposal 2006 Decision on FP7 2007
First funding of research grants to
individual teams
20
Technology Platforms

• Rationale
• To contribute to competitiveness (Lisbon goal),
  boost research performance (ERA, 3 target) and
  concentrate efforts and address fragmentation
• Characteristics
• To address challenging social and economic
  issues, embodying major technological advances
  and high research intensity and requiring a
  European level approach to provide high Community
  added value
• Approach
• Gather a wide stakeholder base (industry, public
  authorities, research community, financial
  community, standardisation bodies, regulators,
  civil society, consumers / end-users) and
  mobilise private and public funding (national,
  regional and Community FWPs, Structural Funds,
  EIB, EUREKA) and integrate education, training,
  communication, dissemination

21
Technology Platforms

• Central Concept
• Framework to unite stakeholders around
• a common long-term vision for the technology
  concerned
• mobilisation of a critical mass of public and
  private research and innovation efforts
• definition of a Strategic Research Agenda and
  roadmap to realise the common vision
• A new instrument is proposed for FP7 to support
  ambitious, large-scale research projects through
  large public-private partnerships
• Joint European Technology Initiave

22
Why plant research matters (1)

• Nearly 8 of the EU25 workforce is employed in
  the agricultural sector and there are more than
  17 million farms.
• The EU food and drink industry is the largest
  European industry in the manufacturing sector
  with a turn over of more than 650 billion and a
  workforce of 2.6 million.
• European forestry and its related industries
  employ more than 3.5 million people with an
  annual turnover of more than 200 billion.
• Livestock production in Europe consumes 400
  million tonnes of feed, including grazing land,
  of which 90 is produced in Europe.

23
Why plant research matters (2)

• Feeding 8,5 billion people by 2025 meeting
  growing demand for high-quality, safe and
  affordable food under the restraint of limited
  availability of arable land (from 0,4 hectare per
  person in 1965 to 0,15 per person in 2050).
• Climate and health-threatening fossil resources
  are limited and need to be replaced by renewable
  resources.
• Making the transition to a more sustainable
  knowledge based bio-economy is as inevitable as
  it is desirable.
• Developing plant genomics and biotechnology is a
  necessary condition to realise the
  knowledge-based bio-economy.

24
Why European research on plants matters!

• European researchers pioneered plant
  biotechnology and genomics, but
• Europe is facing a growing exodus of
  researchers and companies.
• Europe needs to become an incubator for top
  researchers and innovative companies that meet
  demand for better, safer and more environmentally
  friendly products.
• This is not the task of one organisation or one
  country.
• This can only happen through the commitment of
  all stakeholders, working together in a coherent
  fashion at the European level.
• Europe must also commit to sharing the knowledge
  with developing countries in need.

25
Technology Platform Plant genomics and
biotechnology

• Plants for the future vision paper launched on
  24th June 2004 by representatives of research,
  biotech and food industry, farmers, consumers and
  other stakeholders
• Objectives
• Produce better quality, healthy, affordable and
  diverse food offering consumers in and beyond
  Europe real options to improve their quality of
  life
• Bring about environmental and agricultural
  sustainability, including biomaterials,
  bio-energy and renewable resources
• Enhance the competitiveness of European
  agriculture, food and biotech and other related
  industries

26
Technology Platform Plant genomics and
biotechnology

• TP secretariat jointly run by EPSO and EuropaBio
• Advisory Council and Steering Committee currently
  being established
• Strategic research agenda to be developed by 4
  working groups
• Basic plant genomics research
• Sustainable agriculture
• Plants for food and non-food products
• Horizontal issues group (training, consumer
  issues, regulatory issues, etc.)
• More infos from www.epsoweb.org

27
THE FUTURE KNOWLEDGE BASED BIO-ECONOMY
Consumer choice
Consumer choice
Renewable biomaterials Bioenergy Environmental
technologies
Safe/healthy/diverse food supply
WHITE BIOTECH CLEAN BIOPROCESSES OF RAW
MATERIALS/WASTE
DOWN STREAM PROCESSING MEMBRANE TECHNOLOGIES
PROCESSING
GREEN/BLUE BIOTECH OPTIMISED RAW MATERIALS
PRODUCTION
RURAL DEVELOPMENT- LOW INPUT FARMING-
BIODIVERSITY
SUSTAINABLE MANAGEMENT OF BIOLOGICAL
RESOURCES (LAND, FOREST, MARINE)